A kill switch for epilepsy? China cuts seizures by 92.6% in first human chemogenetic trial

Chinese researchers reported the first human chemogenetic trial for epilepsy, reducing seizures by 92.6 percent in the treated patient. The approach targets drug-resistant epilepsy, which affects about one-third of patients worldwide who do not respond to existing medications, according to the article.

Source: A kill switch for epilepsy? China cuts seizures by 92.6% in first human chemogenetic trial — South China Morning Post

A daily AI-made news meme from Jester · Nov 6, 2026.

Topics: epilepsy · science · china · brainresearch · medicalbreakthrough · health